Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Booth

Showing results (161-170 of 349) with videos related to

Pageof 35
Sort By:
JAMA Oncology|April 28, 2022
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug ClassJoseph N Samuel, Christopher M Booth, Elizabeth Eisenhauer, et al.
Urologic Oncology|February 11, 2014
Why is perioperative chemotherapy for bladder cancer underutilized?Francis M Patafio, William J Mackillop, Deb Feldman-Stewart, et al.
Journal of Global Oncology|July 2, 2019
Breast Cancer Care in South India: Is Practice Concordant With National Guidelines?D K Vijaykumar, Sujana Arun, Aswin G Abraham, et al.
Breast Cancer Research and Treatment|September 16, 2016
The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysisMichael J Raphael, James J Biagi, Weidong Kong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 9, 2014
Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based studyDavid M Berman, Atsunari Kawashima, Yingwei Peng, et al.
Journal of Cancer Policy|January 24, 2023
Are the Choosing Wisely Canada Cancer recommendations relevant and up to date with the current evidence?Safiya Karim, Corinne M Doll, Brittany Dingley, et al.
The Lancet. Gastroenterology & Hepatology|December 22, 2018
Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based studyJennifer A Flemming, Yvonne Dewit, Jeffrey M Mah, et al.
Journal of Oncology Practice|August 21, 2014
Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon CancerDavid W Wasserman, Majdi Boulos, Wilma M Hopman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 1, 2026
Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That MatterSamuel X Stevens, Michelle Leah Tregear, Rachel Riechelmann, et al.
JAMA Oncology|September 27, 2019
The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer: A Systematic Review and Qualitative Assessment of the LiteratureMichael J Raphael, Andrew Robinson, Christopher M Booth, et al.
Pageof 35

Showing results (161-170 of 349) with videos related to

Sort By:
Pageof 35
JAMA Oncology|April 28, 2022
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug ClassJoseph N Samuel, Christopher M Booth, Elizabeth Eisenhauer, et al.
Urologic Oncology|February 11, 2014
Why is perioperative chemotherapy for bladder cancer underutilized?Francis M Patafio, William J Mackillop, Deb Feldman-Stewart, et al.
Journal of Global Oncology|July 2, 2019
Breast Cancer Care in South India: Is Practice Concordant With National Guidelines?D K Vijaykumar, Sujana Arun, Aswin G Abraham, et al.
Breast Cancer Research and Treatment|September 16, 2016
The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysisMichael J Raphael, James J Biagi, Weidong Kong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 9, 2014
Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based studyDavid M Berman, Atsunari Kawashima, Yingwei Peng, et al.
Journal of Cancer Policy|January 24, 2023
Are the Choosing Wisely Canada Cancer recommendations relevant and up to date with the current evidence?Safiya Karim, Corinne M Doll, Brittany Dingley, et al.
The Lancet. Gastroenterology & Hepatology|December 22, 2018
Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based studyJennifer A Flemming, Yvonne Dewit, Jeffrey M Mah, et al.
Journal of Oncology Practice|August 21, 2014
Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon CancerDavid W Wasserman, Majdi Boulos, Wilma M Hopman, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 1, 2026
Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That MatterSamuel X Stevens, Michelle Leah Tregear, Rachel Riechelmann, et al.
JAMA Oncology|September 27, 2019
The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer: A Systematic Review and Qualitative Assessment of the LiteratureMichael J Raphael, Andrew Robinson, Christopher M Booth, et al.
Pageof 35